JIANGSU HENGRUI MEDICINE CO., LTD.

Analyst Reco. Jiangsu Hengrui Medicine Co., Ltd.

Equities

600276

CNE0000014W7

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-05-05 pm EDT			5-day change	1st Jan Change
47.16 ^CNY	+2.17%		+2.12%	+4.27%

Apr. 26	Hengrui Pharma Gets Nod to Trial Insulin Aspart Injection; Shares Up 3%	MT
Apr. 17	Jiangsu Hengrui Medicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Nomura Adjusts Jiangsu Hengrui Medicine’s Price Target to 51.12 Yuan From 49.24 Yuan, Keeps at Neutral	Mar. 15	MT
Nomura Adjusts Jiangsu Hengrui Medicine's Price Target to 49.24 Yuan From 50.19 Yuan, Keeps at Neutral	23-10-17	MT
Nomura Adjusts Jiangsu Hengrui Medicine's Price Target to 50.19 Yuan From 46.30 Yuan, Keeps at Neutral	23-07-25	MT
Nomura Adjusts Jiangsu Hengrui Pharmaceuticals' Price Target to 46.30 Yuan From 41.29 Yuan, Keeps at Neutral	23-04-24	MT
Nomura Adjusts Jiangsu Hengrui Medicine's Price Target to 41.29 Yuan From 38.29 Yuan, Keeps at Neutral	23-03-09	MT
Nomura Adjusts Jiangsu Hengrui Pharmaceuticals' Price Target to 34.13 Yuan From 31.71 Yuan, Keeps at Neutral	22-08-22	MT
Nomura Adjusts Jiangsu Hengrui Pharmaceuticals' Price Target to 31.71 Yuan From 55.66 Yuan, Keeps at Neutral	22-04-25	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW